REPROCELL INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139 JPY | -2.11% |
|
+2.96% | -20.57% |
Chart calendar ReproCELL Incorporated
01ddc322799ca604e58e34563e38.G0GNdNCjrSoEorgqvox_Ft56RmmJLNiUvg0iyPRspJ4.SB7uIJbR6R9j-uhuycRJbrZLKhjnTrX30VRph70jnPMpEbwx4PL_S0bp4Q~9b51127f1bd56507702ac410d4a26812
Upcoming events on ReproCELL Incorporated
Past events on ReproCELL Incorporated
| 09/02/2024 | Q3 2023 Earnings Release |
| 10/11/2023 | Q2 2023 Earnings Release |
| 10/08/2023 | Q1 2023 Earnings Release |
| 22/06/2023 | Shareholders Meeting |
| 12/05/2023 | Q4 2022 Earnings Release |
| 10/02/2023 | Q3 2022 Earnings Release |
| 09/11/2022 | Interim 2022 Earnings Release |
| 10/08/2022 | Q1 2022 Earnings Release |
| 13/05/2022 | FY 2021 Earnings Release |
| 10/02/2022 | Q3 2022 Earnings Release |
| 12/11/2021 | Interim 2021 Earnings Release |
| 13/08/2021 | Q1 2021 Earnings Release |
| 12/05/2021 | FY 2020 Earnings Release |
| 12/02/2021 | Q3 2020 Earnings Release |
| 12/11/2020 | Interim 2020 Earnings Release |
| 14/05/2020 | FY 2019 Earnings Release |
| 13/02/2020 | Q3 2019 Earnings Release |
| 09/08/2019 | Q1 2019 Earnings Release |
| 14/05/2019 | FY 2018 Earnings Release |
| 13/02/2019 | Q3 2018 Earnings Release |
Annual results
| Fiscal Period | Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 1 088 1 200 -9.33% | 1 199 1 200 -0.08% | 1 286 1 290 -0.31% | 2 234 2 060 8.45% | 2 953 2 810 5.09% | 2 630 |
|
EBITDA Million JPY | Released Forecast Spread | -729 -760 4.12% | -843 -870 3.14% | -987 -1 050 6.04% | -587 -610 3.71% | -176 -160 -9.76% | -400 |
|
EBIT Million JPY | Released Forecast Spread | -781 -860 9.19% | -908 -910 0.22% | -1 048 -1 100 4.73% | -647 -670 3.43% | -356 -220 -61.82% | -460 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -627 -810 22.59% | -1 015 -1 010 -0.5% | -811 -950 14.63% | -573 -400 -43.25% | -303 -70,0 -332.86% | -260 |
|
Net income Million JPY | Released Forecast Spread | -601 -810 25.8% | -1 016 -1 010 -0.59% | -812 -950 14.53% | -575 -400 -43.75% | -305 -70,0 -335.71% | -260 |
|
EPS JPY | Released Forecast Spread | -8,79 -11,4 22.89% | -14,3 -14,1 -0.92% | -11,4 -13,3 14.31% | -7,57 -4,52 -67.48% | -3,62 -0,82 -341.46% | -3,05 |
| Announcement Date | 14/05/19 | 10/07/20 | 12/05/21 | 13/05/22 | 12/05/23 | - |
Quarterly results
| Fiscal Period | Maart | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 564 | 614 | 989 | 499 450 10.89% | 746 572 30.42% | 666 370 80% | 910 613 48.39% | 1 576 | 647 670 -3.43% | 730 587 24.42% | 556 550 1.09% | 591 564 4.86% | 1 147 | 629 720 -12.64% | 853 |
|
EBIT Million JPY | Released Forecast Spread | -432 | -502 | -359 | -170 -230 26.09% | -118 -141 16.31% | -86,0 -200 57% | -4,00 -93,3 95.71% | -90,0 | -117 -80,0 -46.25% | -149 -12,7 -1069.64% | -124 -140 11.43% | -117 -116 -0.93% | -241 | -48,0 -90,0 46.67% | -171 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -434 | -365 | -201 | -150 | 42,0 | 70,0 | -106 | 73,0 | 61,0 | -12,0 | |||||
|
Net income Million JPY | Released Forecast Spread | -436 | -365 | -201 | -150 | 42,0 | 68,0 | -107 | 72,0 | 60,0 | -12,0 | |||||
|
EPS JPY | Released Forecast Spread | -6,13 | -5,13 | -2,79 | -1,95 -9,22 78.85% | -2,83 0,22 -1386.36% | 0,51 -1,46 134.93% | 0,31 -1,24 125% | 0,82 | -1,29 -0,94 -37.23% | -3,15 -0,35 -800% | 0,85 -0,23 469.57% | -0,14 -2,14 93.46% | 0,71 | -0,14 -0,94 85.11% | -3,62 |
| Announcement Date | 13/11/19 | 12/11/20 | 12/11/21 | 10/02/22 | 13/05/22 | 10/08/22 | 09/11/22 | 09/11/22 | 10/02/23 | 12/05/23 | 10/08/23 | 10/11/23 | 10/11/23 | 09/02/24 | - |
| 06/05/2024 04:30 pm | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 07/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 11:30 am | BIOGAIA AB: Q1 2024 Earnings Release |
| 07/05/2024 05:00 pm | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
| 08/05/2024 05:25 pm | VERICEL CORPORATION: Q1 2024 Earnings Release |
| 09/05/2024 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
Past sector events for ReproCELL Incorporated
| 03/05/2024 01:35 am | TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release |
| 02/05/2024 05:20 pm | ARBUTUS BIOPHARMA CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 05:00 pm | BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release |
| 30/04/2024 04:30 pm | INCYTE CORPORATION: Q1 2024 Earnings Release |
| 30/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release |
| 30/04/2024 | SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release |
| 30/04/2024 03:23 am | SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release |
| 29/04/2024 | SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4978 Stock
- Calendar ReproCELL Incorporated
